Sixty-two cases of intractable ascites due to cirrhosis treated by the modified Wulingsan power plus abdominal reinfusion of the concentrated ascites after ultrafiltration.

Objective: To observe the clinical therapeutic effects of Wulingsan Jiawei ([Chinese characters: see text] Supplemented Powder of Five Drugs with Poria, SPFDP) plus abdominal reinfusion of concentrated ascites after ultrafiltration (ARCAU) for intractable ascites due to cirrhosis (IAC).

Methods: 124 cases of IAC were randomly divided into two groups, a treatment group of 62 cases treated by oral administration of SPFDP plus ARCAU and a control group of 62 cases treated simply by ARCAU. Aldosterone (ALD) level in plasma, levels of total bilirubin (TBIL) and albumin (ALB) in serum, and activity of alanine aminotransferase (ALT) were determined in the two groups before and after treatment.

[A clinical observation on therapeutic effect of colon purification on hepatic encephalopathy].

Objective: To observe therapeutic effect of colon purification on hepatic encephalopathy.

Methods: 117 patients with hepatic encephalopathy treated in our hospital were randomly divided into the treatment group (59 cases) and the control group (58 cases). Routine anti-coma hepaticum treatments were carried out in both treatment and control groups, and colon purification treatment was performed in the treatment group on basis of routine anti-coma hepaticum.